Introduction
Dyspnoea in the upright position that is relieved by resuming the supine posture was first described by Burchell et aI. (1) in 1949, and later Altman and Robin (2) coined the term 'platypnoea'
(from the Greek words platys=recumbent and pnoezbreath). This is a rare form of dyspnoea and is usually accompanied by arterial desaturation in the upright position that is improved during recumbency, a condition that is called orthodeoxia (from the Greek words orthos=upright and deoxia=desaturation). Both platypnoea and orthodeoxia have been described in patients with different underlying conditions (2-28) ( Table 1) .
To our knowledge, the platypnoea-orthodeoxia couple has not been previously described in a patient with severe organophosphorus (OP) poisoning.
Case Report
A 60-year-old farmer was admitted to the intensive care unit after attempting suicide by ingesting an unknown quantity of the OP insecticide dimethoate 2 h previously. On admission the patient was in deep coma, Glasgow coma scale (GCS) 4, had pinpointsized pupils and reduced muscle tone and tendon Received 14 January 1995 and accepted 20 January 1995. §Author inspired oxygen taken after 1 h mechanical ventilation was 320. The abdominal wall was soft, there were increased bowel sounds and sialorrhea. Bouts of diarrhoea started 4 h after admission and lasted for 3 days. The patient was intubated and resuscitated, and mechanical ventilation started. Atropine was given as boluses of 2 mg every 10 min up to 6 mg and subsequently continued as infusion of 0.016 to 0.05 mg kg-i h ~ i for 23 days (cumulative dose 649 mg). Pralidoxime (ZPAM) was given as boluses of 1 g 4 and 6 h after admission, and then as 500 mg q.i.d. for 12 days (cumulative dose 24 g). The dose of atropine was adjusted in order to: (i) minimize bronchial secretions; (ii) maintain pupil size as greater than 3 mm; and (iii) keep the heart rate greater than 100 beats min-'. The dose of pralidoxime was also adjusted aiming to: (i) normalize acetylcholinesterase (Ache) serum levels, i.e. greater than 3.5 U 1 -'; and (ii) normalize the neuromuscular response, checked clinically and by a relaxograph (Datex, Finland) .
The remaining therapy included gastric lavage with activated charcoal and manitol every 3 h for the first 24 h, until gastric lavage was free of poison.
Laboratory results on admission were: haematocrit 44%; Hb 14 g dl-'; serum urea 6 mm01 1 -i (reference values 2.2-9 mm01 1 -'); serum creatinine 133 mm01 l-' (range 65-141 mmol l-'); K+ 2.92 meq 1~ ' (range 3.5-5.5 meq 1 -'); Na+ 152 meq 1 -' (range 135-145 meq l-'); Ca2+ 2 mm01 1 -' (range 2.2-2.58 mmol 1 -'); aspartate aminotransferase (SGOT) 70 U 1 -i (range 15-35 U 1 -I); alanine aminotransferase (SGPT) 67 U 1 -' (range 9-39 U 1 -I); lactate dehydrogenase 500 U 1 -' (range 70-280 U 1 -'); and creatine kinase 280 U 1 -' (range 25-l 85 U 1 -I).
The patient was evaluated twice daily by the same doctor for the severity of his condition (APACHE II score), central nervous system function (GCS score), respiratory function (Murray's Acute Lung Injury score) (29), and the skeletal muscle function (clinical examination, relaxogram). The toxicological analysis for dimethoate quantitation by gas chromatography (30) in biological samples gave the following results: serum levels 9.3pgml-', gastric fluid 18 mg ml ~ ' and urine 43 pug ml -' . Serum levels of dimethoate returned to non-toxic levels (<0,05pg ml-') 15 days later. Ache serum levels on admission and during the following days determined spectrophotometrically (Boehringer Mannheim kit) are shown in Fig. 1 . Plasma Ache activity on admission was 480 U 1 -' (reference values 3.5-8.5 U l-'), and reached the lower normal range on the twelfth hospital day.
The course of the disease was prolonged, requiring mechanical ventilation for 30 days, atropine therapy for the first 23 days and pralidoxime administration for 12 days (Fig. 2) .
Clinical examination sho&d that the first skeletal muscle to recover was the diaphragm, followed by the muscles of the extremities. The intercostal muscles did not show any clinical activity and the patient had a diaphragmatic type of breathing. The weaning trial of the patient from the mechanical ventilation started 20 days after admission, initially on intermittent mandatory ventilation (IMV) mode, and 6 days later on continuous positive airways pressure (CPAP) (7.5-12.5 cm H,O) for 4 days. On the thirtieth day, after the patient had been stable for 3 days breathing 40% 0, through a tracheostomy and a T-piece, he was put into the sitting position. Minutes later, he developed acute respiratory distress (tachypnoea, tachycardia, cold perspirations, upper chest inspiratory infold and severe cyanosis). Arterial PaO, dropped from 85 to 40 mmHg (SaO, from 95
All the previously described causes and related abnormal states (Table 1) Although it is obvious that the patient developed a severe and protracted intermediate syndrome after an acute cholinergic crisis both due to OP poisoning, the reason for platypnoea-orthodeoxia is not clear. One possible explanation is the earlier resuming of activity of the diaphragm in relation to intercostal muscles. However, this is based only on the observation of the diaphragmatic type of breathing of the patient. It has been shown that selective contraction of different respiratory muscles may result in changes in the vertical gradient of pleural surface pressure and lung volume, although in normal subjects it appears to be more prominent in the horizontal positions (32-33). In support of this as a cause of platypnoeaorthodeoxia is the improvement of oxygen saturation on the patient's placement on face CPAP, an observation that has not been reported previously. Indeed, small airways closure or microatelectasis has been suggested as the cause of the observed ventilationperfusion mismatch in platypnoea-orthodeoxia (22) which may have reversed by applying CPAP.
Another explanation could by the automatic nervous system dysfunction as a result of OP poisoning. In this case, when the patient is erect the underlying to 70%). The systemic arterial pressure didn't change significantly and the patient recovered by resuming the supine position. The same episode was induced and repeated whenever the patient was put in the sitting position (orthodeoxia) and was relieved in the supine position (platypnoea).
Interestingly, the syndrome was totally alleviated by simple substitution of a T-piece to CPAP (7.5 cm H,O) (Fig. 1) Fig. 2 .
The patient was discharged 45 days after admission, much improved, without symptoms of platypnoea or orthodeoxia, and with no need for supplemental oxygen. After 4 months, he was able to return to work.
Discussion
This report documents a 60-year-old man who developed platypnoea and orthodeoxia after mechanical ventilation for severe OP poisoning. To our knowledge, this is the first case of platypnoea and orthodeoxia described in relation to this condition. seems impossible in our case because the blood pressure was stable even after the CPAP application.
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An intracardiac shunt as a possible cause of platypnoea-orthodeoxia was excluded by contrast echocardiography done in both the recumbent and 17. sitting positions.
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